News and Commentary

Here Are My Ten Takeaways From The HHS Pediatric Gender Medicine Review

The medical risk to minors posed by puberty blockers, cross-sex hormones, and surgeries significantly outweighs any benefits.

Jesse Franklin-Murdock
Here Are My Ten Takeaways From The HHS Pediatric Gender Medicine Review
Credit: Vladimir Vladimirov via Getty Images.

As a lawyer who represents detransitioners like Chloe Cole in medical malpractice cases and parents fighting for the right to notice and consent before public schools may socially transition their children, I am all too familiar with how bad science gets laundered in pediatric gender medicine. For the record, a detransitioner is an individual who medically transitioned but now identifies and presents as their natal sex.

Activists take over medical associations (most notably, the World Professional Association for Transgender Health or WPATH) and use the imprimatur of those organizations to justify providing children with puberty blockers, cross-sex hormones, and even irreversible surgeries. The unreliability of much of the medical literature on pediatric gender medicine makes the U.S. Department of Health and Human Services’ recent report, Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices, a necessary development in the field.

Got a tip worth investigating?

Your information could be the missing piece to an important story. Submit your tip today and make a difference.

Submit Tip